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Abstract
Transcription activator-like effector nucleases (TALENs) enable genome engineering in cell culture and many organisms.
Recently, the GoldyTALEN scaffold was shown to readily introduce mutations in zebrafish (Danio rerio) and livestock through
non-homologous end joining (NHEJ) and homology-directed repair (HDR). To deploy the GoldyTALEN system for high-
throughput mutagenesis in model organisms, a simple design with high efficacy is desirable. We tested the in vivo efficacy
of a simplified 15-RVD GoldyTALEN design (spacer between 13–20 bp and T nucleotide preceding each TALEN binding site)
in zebrafish. All 14 tested TALEN pairs (100%) introduced small insertions and deletions at somatic efficacy ranging from 24
to 86%, and mutations were inheritable at high frequencies (18–100%). By co-injecting two GoldyTALEN pairs, inheritable
deletions of a large genomic fragment up to 18 kb were successfully introduced at two different loci. In conclusion, these
high efficiency 15-RVD GoldyTALENs are useful for high-throughput mutagenesis in diverse application including
hypothesis testing from basic science to precision medicine.
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Introduction
Custom restriction enzymes including zinc finger nucleases
(ZFNs) and transcription activator-like effector nucleases (TA-
LENs) are valuable tools in genome editing (for review, see
Carlson, D.F. et al [1]). Both encode a FokI nuclease catalytic
domain fused with a customizable DNA binding domain that
determines their targeting specificity. The ability of ZFNs to
introduce targeted double-stranded breaks in a genome can be
used to introduce small insertion-deletions (indels) through non-
homologous end joining (NHEJ) [2–12] in vivo or targeted
sequence changes by homology directed repair (HDR) in vitro
[13,14]. Compared with ZFNs, TALENs have generated consid-
erable interest because of their simple and straightforward cipher
code that guides DNA binding domain design, which is based on a
33–35 amino acid repetitive sequence [15,16]. Each repeat
encodes a single nucleotide binding specificity determined by the
Repeat Variable Di-residues (RVDs) [15,16]. TALENs can
therefore be customized for targeting genomic sequence by
assembling corresponding RVDs through highly developed
methods [17–21].
TALENs have been used extensively in genome editing in vitro
and in vivo in cells [18,22,23] and in many diverse species [24–27].
Recently, we reported a GoldyTALEN scaffold [28] with high
efficiency as compared to other previously reported TALEN
systems [25,29–32] or ZFNs [8,32] in zebrafish genome editing.
GoldyTALENs were able to not only introduce small insertion-
deletions (indels) [26,28], but also enable new genome engineering
approaches like targeted mutations via HDR [28].
The TALEN field has been implementing a range of systems
and design approaches. In addition to related but divergent
scaffolds, there are other common differences in TALEN designs,
including the use of alternate-style RVDs, RVD composition,
length of the DNA binding motif, as well as the spacer length
between TALEN arms; these various guidelines for TALEN
designs have been published previously based on other scaffolds or
model systems [17,20,33–35]. One recent study suggests that
several of these rules do not dictate TALEN efficiency in zebrafish,
however, leaving the community with little direction when
deciding on TALEN design [32]. Given these diverse protocols
with highly variable activities, a simple yet flexible GoldyTALEN
design with a high success rate for generating active reagents
would be a valuable addition to the science community. Here, we
report a simplified 15-RVD TALEN design with high in vivo
genome targeting efficiency. We used these TALENs to engineer
with high success targeted large deletions in this increasingly
important animal model system, the zebrafish.
Materials and Methods
Zebrafish
All zebrafish work was completed under pre-approved animal
care and use guidelines approved by the Mayo Clinic Institutional
Animal Care and Use Committee.
Design of GoldyTALENs
All TALEN pairs were designed using Mojo Hand software
(www.talendesign.org) [36], which is a freely accessible web-based
PLOS ONE | www.plosone.org 1 May 2013 | Volume 8 | Issue 5 | e65259
tool to design TALENs with editable parameters and other
features including the identification of a unique restriction site in
the spacer sequence (Figure 1). Initial design parameters included
15-RVD (or 14.5 TALE repeats) TALENs targeting sites with a T
nucleotide 59 upstream of TALEN targeting sites and spacer
lengths between 11–20 base pair (bp) with a unique restriction site
close to the middle of the spacer sequence for screening of small
indels induced through NHEJ. Modifications were made to these
parameters later in the study as described. Specificity of TALENs
was examined using NCBI Primer-BLAST (Table S4). All loci
were amplified from wild-type fish and sequence determined to
avoid any polymorphisms or mismatches within the TALEN
binding site or the spacer.
Synthesis of GoldyTALENs
All TALEN constructs were synthesized with the Golden Gate
method [17] using the GoldyTALEN scaffold [28] (Figure 2). The
highly active RVD NN was used to target G nucleotide rather
than the lower activity RVDs NK [34] or NH [35]. In the first
Golden Gate reaction, intermediate constructs containing TALE
repeats 1 to 10 and 11–14 were separately synthesized in pFUS_A
and pFUS_B4 vectors, respectively. The two TALE repeat arrays
from pFUS_A and pFUS_B4 as well as the last half-repeat carried
in either pLR-NI, -HD, -NN or –NG were combined in the
second Golden Gate reaction in the RCIscript-GoldyTALEN
expression vector. GoldyTALEN constructs were subsequently
linearized by SacI, and mRNA encoding each TALEN arm was in
vitro transcribed using the mMESSAGE mMachine T3 Kit (Life
Technologies, Grand Island, NY, USA).
Injection of GoldyTALENs and screening for somatic
mutations in zebrafish
The two mRNAs encoding each TALEN pair were injected into
the cytoplasm of 1-cell stage wild-type zebrafish embryos, except
the GFP(GM2) P1 TALEN pair that was injected into GFP
transgenic line Tg(GBT309) [37]. Genomic DNA was extracted
from both single and groups of 10 embryos at 48 hours-post-
fertilization (hpf). Somatic small indels resulting from NHEJ were
screened and quantified using a RFLP assay as previously
described [28] (Table S5). To normalize variation between single
embryos, TALEN activities were measured from genomic DNA
extracted from a group of 10 embryos. Large deletions resulted
from co-injecting 2 TALEN pairs were screened by PCR with
primers flanking the 2 TALEN cutting sites (Table S5).
Quantitative PCR (qPCR) with primers within the corresponding
deleted fragments was used to estimate the percentage of large
deletions in TALEN-injected embryos, with primers at an
irrelevant locus used as an internal reference (Table S5). For all
screening, only phenotypically normal embryos injected at the
highest tolerated dose (.50% normal embryos at 48 hpf) (Table
S6) were analyzed.
Screening for germline transmitted deletions
Phenotypically normal injected embryos (same batch of those
screened for somatic mutations) were raised and tail fins were
biopsied after 8-weeks to screen for maintenance of induced
mutations, as described [28]. Fish with positive fin-clip results were
subsequently out-crossed with wild-type fish after 12-weeks, and
F1 progeny were screened for germline mutations.
Synthesis of pFUS_B4 collection
The complete collection of 256 pFUS_B4 (with all possible 4-
RVD combination) used in the Golden Gate synthesis of 15-RVD
TALENs was synthesized initially through a mix-reaction
approach. Either NI, HD, NN or NG were added at position 1
and all 4-RVDs were added for position 2 to 4 in a single Golden
Gate reaction to synthesized up to 256 possible pFUS_B4 clones in
4 reactions. Around 80% of possible combinations were identified
through screening 192 colonies from each of the 4 reactions, and
the remaining pFUS_B4 clones were synthesized individually
Statistical analysis
The TALEN activities were calculated as the means of three
separate experiments with the standard error of the means. To
analyze the relationship between TALEN activity and weak RVDs
(NI and NG) composition, the linear correlation coefficient was
defined from the plot of individual TALEN activities against their
percentages of weak RVDs as defined [35].
Results
Somatic screening showed a high success rate of the 15-
RVD GoldyTALEN design
TALENs are assembled as pairs for genome editing applica-
tions, with a wide range of lengths (9 to 30-RVD, including the
final half repeat) for each arm reported to show activity [17–
20,35]. Notably, some TALENs as short as 15-RVDs (14.5 TALE
repeats) have been shown to exhibit high activities [20,27],
consistent with the reported structural work demonstrating 15
bases of sequence recognition by TAL domains [38,39]. Together,
these data suggested that 15-RVD TALENs might be a simplified
yet effective TALEN design approach. 15-RVD GoldyTALEN
pairs (Figure 1) targeting nine loci in five zebrafish genes and GFP
(Table S1) were designed based on these initial parameters
(Figure 1 and see Methods section), and their in vivo activity was
tested in zebrafish embryos. 11 out of 13 15-RVD GoldyTALEN
Figure 1. Design of 15-RVD GoldyTALENs. The design parameters of active 15-RVD GoldyTALEN pairs used in this study. Each TALEN arm
consists of a DNA binding domain with 15-RVDs (14.5 TALE repeats), corresponding to 15-nucleotides DNA binding sequence proceeded by a 59 T
nucleotides and a 13 to 20 bp spacer in between 2 arms containing a restriction recognition sequence to assay activity. *Initial design parameter was
spacer length between 11–20 bp and only the two inactive pairs, NPM1B P1 and P2 have spacers shorter than 13 bp.
doi:10.1371/journal.pone.0065259.g001
15-RVD GoldyTALEN
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pairs we tested showed efficient targeting, ranging from 24 to 84%
chromosome conversion rate (Figure 3A and Figure S1). Two pairs
targeting npm1b (NPM1B P1 and P2) showed significantly reduced
activity compared to the other GoldyTALENs (Figure 4A and B).
Bi-allelic chromosomal conversion, a hallmark of the Gold-
yTALEN system in zebrafish [28], was detected in 3 out of 13
TALEN pairs (Figure 3B).
Spacer length and the 59 T nucleotide are important for
TALEN activity
One recent study proposed a hypothesis to distinguish and
predict high efficacy from low efficacy TALENs by suggesting that
RVDs could be sorted into ‘strong’ or ‘weak’ categories [35]. To
better understand the basic requirements of an active Gold-
yTALEN pair, we correlated TALEN activity with the composi-
tion of strong (HD, NN) or weak (NI, NG) RVDs as well as the
spacer length. No direct correlation between TALEN activity and
the relative composition of different RVDs was noted (correlation
coefficient =20.149, Figure S2 and S3). However, NPM1B P1
and P2 with significantly reduced activity had a shorter spacer of
12 and 11 bp while all other successful GoldyTALENs were
$13 bp (Table 1). To test if the spacer length is critical for
TALEN activity, both left (NPM1B P1 LS) and right arms
(NPM1B P1 RS) of NPM1B P1 were redesigned for a longer
spacer (15 bp) while keeping a 59 T nucleotide in place (Figure 4A).
Shifting either side of the pair significantly restored the 15-RVD
TALEN activity to 8367 and 7168% (Figure 4B). Furthermore,
the 59 T nucleotide found upstream of most active TALEN
binding sites was tested for its importance in GoldyTALEN
activity. The right and left arms of IDH1 P1 and JAK2A P1,
respectively, were shifted one base to remove the 59 upstream T
nucleotide (Figure 4C). Interestingly, the activity of these modified
TALEN pairs (IDH1 P1 RM and JAK2A P1 LM) was greatly
reduced to 1564 and 962% (Figure 4D), unambiguously
demonstrating an important functional role for this base in TALE
DNA binding.
Targeted deletion could be introduced by co-injecting
two pairs of TALEN
Genetic nulls are classically defined as physical deficiencies in a
particular locus. The high activity of GoldyTALENs and the early
data from TALEN work using the silkworm [40] suggested that
injecting two pairs of TALENs could be a viable approach to
specifically delete a large contiguous region of the genome. To test
whether 15-RVD GoldyTALENs would work in this capacity in
zebrafish, either FLT3 P1 and P3 or JAK2A P1 and P4 TALEN
pairs were injected into zebrafish embryos, an approach expected
to delete fragments sized around 16 kilobases (kb) and 18 kb,
respectively (Figure 5). PCR screening indicated a high penetrance
of the expected large deletions by both TALEN combinations at
the somatic cell level, detected in 81611% (FLT3 P1/P3) and
8469% (JAK2A P1/P4) of injected embryos. The percentage of
deletion in injected embryos was 2763% (FLT3 P1/P3) and
1964% (JAK2A P1/P4) as estimated by qPCR.
Mutations introduced by 15-RVD TALENs are inheritable
To test if the small indels and large deletions induced by 15-
RVD TALEN pairs were inheritable, embryos injected with FLT3
P2, NPM1B P1 LS, NPM1A P1 or NPM1A P2 as well as embryos
co-injected with FLT3 P1/P3 or JAK2A P1/P4 were raised to
sexual maturity. Injected fish with stable mutations in DNA from
adult tail tissue were subsequently out-crossed and their progeny
were screened for germline-transmitted mutations. Encouragingly,
expected mutations from all six batches were transmitted to the
germline at a high frequency. 18 to 100% of screened F0 embryos
injected with a single GoldyTALEN pair carry germline mutations
of small indels whereas 28 and 31% of screened F0 embryos carry
germline mutations of large deletions, respectively, at flt3 and jak2a
loci. (Figure 5B, Table S2 and S3).
Figure 2. Synthesis of 15-RVD GoldyTALENs. A schematic diagram showing the assembly of 15-RVD GoldyTALENs by the Golden Gate method
described earlier [17]. The RCIscript-GoldyTALEN backbone, all other component plasmids (as Golden Gate TALEN kit 2.0), and the 256 pFUS_B4
clones are distributed through Addgene. *XX denoted either NI, HD, NN or NG.
doi:10.1371/journal.pone.0065259.g002
15-RVD GoldyTALEN
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Discussion
Recent advances in TALEN technology have shaped this
custom restriction enzyme system into highly useful genome
engineering tools. Designing an efficient TALEN pair is perhaps
the most crucial step for successful genome engineering. The
extensive nature of the reported guidelines have large variations in
the description of critical details for achieving working activity
with different TALEN systems suggesting that parameters
controlling TALEN activity may be scaffold-specific. Given the
high activity of the GoldyTALEN system described to date, we
investigated flexibility and other constraints in the GoldyTALEN
design. A 15-RVD design was initially chosen because 15 bp at
both arms offered enough DNA binding specificity in silico (Table
S4), and the GoldyTALENs targeting moesina with a 15-RVD right
arm showed high activity in our previous study [28]. Recent
studies also indicated that 15-RVD DNA targeting site is the
minimum length for an effective TALEN [20] with minimal off-
target effects [35]. In this study, we chose to use RVD NN to
target all G residues because studies suggested that though NK or
NH has higher specificity towards G residue, TALE domains with
NN showed highest activity [34,35]. Further study is needed to
draw conclusions comparing the efficiency of NN and NH in the
GoldyTALEN scaffold.
Initial screening data showed a high success rate with 12 out of
14 TALEN pairs showing somatic chromosomal conversion
activity beyond 19%; the only 2 exceptional pairs were NPM1B
P1 and P2. Since these TALENs had the shortest spacers (12 and
11 bp) among the cohort, we investigated if we could restore their
activity by simply modifying the spacer. Extending the spacer of
NPM1B P1 to 15 bp by shifting either left or right arm 3 bp while
keeping other variables constant significantly restored the activity
indicating that 15-RVD TALEN pairs need at least a 13 bp
spacer. On the other hand, there is no clear correlation between
TALEN activity and RVD compositions. Although both NPM1B
P1 and P2 had a relatively high percentage of proposed ‘weak’
RVD (NI and NG), the high activity of NPM1B P1 LS and RS,
sharing a similar RVD composition with NPM1B P1, suggests that
spacer length is more important than RVD composition. In
addition, to determine if the 59 T nucleotide is necessary for
TALEN activity, IDH1 P1 and JAK2A P1 were modified such
that one of the TALEN arms did not follow a T nucleotide.
Interestingly, removal of the T nucleotide at only one arm greatly
reduced TALEN activity, highlighting the importance of the
preceding nucleotide at least in the 15-RVD GoldyTALEN
design.
The ability to obtain engineered modifications within the
germline is crucial for genome editing. Consistent with our
previous study with GoldyTALENs [28], small indels introduced
by 15-RVD GoldyTALENs with relatively high (FLT3 P2,
NPMB1 LS) or low (NPM1A P1, NPM1A P2) activities were
transmitted to the germline at high frequencies. A larger genomic
deletion could be introduced in vivo using two pairs of TALENs in
the silkworm [40], and we investigated if these highly active 15-
RVD GoldyTALENs could serve the same purpose. At both loci
tested, large deletions up to 18 kb were successfully introduced
and also transmitted through the germline with high efficiencies
(13–58% transmission rate from individual founder fish to F1
offspring). This strategy could be employed to generate null
zebrafish mutations at critical loci. Recently, Gupta et al [41]
reported the deletion of large genomic sequences in zebrafish using
a similar strategy. Their deletion frequency in somatic tissue of the
F0 embryos and germline transmission rates ranged from 0.7–15%
and 2–13%, respectively, which are lower than the results reported
here. While deletion size differences and locus-specific effects may
also contribute to the observed efficacy differences, we believe the
Figure 3. In vivo activity of 15-RVD GoldyTALENs. (A) In vivo activity (% of chromosome conversion at somatic level) of 15-RVD TALEN pairs.
Results shown were averages of 3 separate experiments analyzing groups of 10 embryos. Error bars represent the standard error of the means. (B)
Representative results of RFLP screening assay after injection of IDH1 P1 and GFP(GM2) P1. Open arrowheads indicate bands from completely
digested WT PCR product and closed arrowheads represent uncut PCR product with small indels. *Marks single embryos with bi-allelic conversion.
doi:10.1371/journal.pone.0065259.g003
15-RVD GoldyTALEN
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higher efficiencies we noted may also result from higher activity of
individual GoldyTALENs. The GoldyTALENs we used to
generate large genomic deletions had activity ranging from 45–
84% compared to the 15–61% activity rates reported by Gupta et
al. Overall, the 15-RVD GoldyTALENs with spacers ranging
from 13–19 bp represent an active design with high success rate.
The only additional substantive design restriction is the require-
ment of the 59T nucleotide upstream. This design can be easily
employed by changing the default parameters of our TALEN
design software, Mojo Hand (www.talendesign.org) [36]. The
average number of TALEN targeting sites identified with unique
restriction sites in the spacer reached 1513 per 1 kb of genomic
fragments in the target loci used here (including overlapping
binding sites), and the number still reached 216 per 1 kb even if we
further restricted the spacer length to 15–17 bp. Given that the
restriction recognition site in the spacer is not an absolute
requirement with the development of melting curve analysis [42],
the flexibility of this design enables efficient targeting almost
anywhere in the genome.
Recently, the CRISPR-associated (Cas) (CRISPR/cas9) [43–
45] system was reported to successfully introduce somatic indels in
zebrafish [46,47]. This RNA-guided system offers the advantage of
easy assembly and the possibility of simultaneously introducing
multiple mutations at the same time. Nevertheless, the present
simple and flexible 15-RVD GoldyTALEN design (with spacer
between 13–20 bp and T nucleotide preceding both TALEN
binding site) offers noticeably higher somatic efficacy (averaging
5866%) and overall success rates using the updated design
parameters (100%) (Figure 6). The requirement of TALENs to
work in pairs may also offer higher specificity compared with the
12–20 recognition nucleotides in the single-guide RNAs [44].
Finally, the reported 15-RVD TALEN assembly by the Golden
Gate method is based on the 10 (pFUS_A)+4 (pFUS_B4)+1 (p-LR)
architecture [17]. The 15-RVD design constraint offers a modified
Figure 4. Importance of the spacer length and the 59 T nucleotide in GoldyTALEN activity. (A) Modifications of NPMB1 P1 to LS and RS for
longer spacers. (B) Both modified NPMBP1 TALEN pairs (NPM1B P1 LS and RS) showed significant increase in in vivo activity compared with the
original shorter spacer design. (C) Modifications of IDH1 P1 and JAK2A P1 to remove the 59 upstream T nucleotide at one of the TALEN arms. (D) Both
modified TALEN pairs (IDH1 P1 RM and JAK2A P1 LM) showed significant reduction in in vivo activity compared with the original designs. Open
arrowheads indicate bands from completely digested WT PCR product and closed arrowheads represent uncut PCR product with small indels. WT:
wild-type; T: TALEN pair injected. Representative and average results of RFLP screening in 3 separate experiments analyzing group of 10 embryos are
shown in the gel photo and graph, respectively. Error bars represent the standard error of the means.
doi:10.1371/journal.pone.0065259.g004
15-RVD GoldyTALEN
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Table 1. Correlation of spacer lengths and somatic activities of 15-RVD GoldyTALENs.
TALEN Pair* Spacer Length (bp) Somatic Activities (% chromosomal conversion)
IDH1 P1 16 8663%*
FLT3 P1 16 8465%*
FLT3 P2 15 8364%*
NPM1B P1 LN 15 8367%*
JAK2A P1 19 7869%
NPM1B P1 RN 15 7168%
FLT3 P3 14 6766%
GFP(GM2) P1 19 5264%
JAK2A P3 18 4563%
NPM1A P1 13 3864%
JAK2A P4 15 3663%
NPM1A P2 18 3566%
JAK2A P5 19 2863%
JAK2A P2 16 2463%
IDH1 P1 RM{ 17 1564%
JAK2A P1 LM{ 18 963%
NPM1B P2 11 361%
NPM1B P1 12 461%
*shown in decreasing order of activity.
{modified without the 59 T nucleotide at one of the TALEN arms.
doi:10.1371/journal.pone.0065259.t001
Figure 5. Deletion of large genomic fragments with two pairs of TALEN. (A) Schematic diagram showing the strategy of introducing large
genomic deletions at flt3 and jak2a loci using two TALEN pairs. Green and purple arrows represent primer pairs used for PCR screening of
corresponding large deletion. WT: wild-type; T: TALEN pairs injected. (B) Sequences of germline-transmitted large deletions in F1 embryos. Sequence
of a single mutant F1 embryo from each founder is shown. Underlined are TALEN binding sites. Sequences in blue represent insertions.
doi:10.1371/journal.pone.0065259.g005
15-RVD GoldyTALEN
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design approach whereby all possible pFUS_B clones could be
pre-assembled. To accomplish this, each of the possible 256
pFUS_B4 clones were assembled into a single collection to
facilitate future 15-RVD TALEN construction that is fully
backward-compatible with the popular Golden Gate assembly
platform of Cermak et al [17] and available through Addgene.
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Figure S1 In vivo activity of 15-RVD GoldyTALENs. Repre-
sentative results of RFLP screening assay of all other 15-RVD
GoldyTALENs tested. Open arrow heads indicate bands from
completely digested WT PCR product and closed arrowheads
represent uncut PCR product with small indels. *An extra
restriction site appears in PCR product outside the spacer resulted
in a 3 bands pattern in WT embryos.
(DOC)
Figure S2 RVD composition of 15-RVD GoldyTALENs. The
RVD sequences of GoldyTALEN pairs and the percentage of
predicted weak RVDs (NI, NG) [35]. *TALEN pairs are shown in
order of decreasing in vivo activity.
(DOC)
Figure S3 Correlation between weak RVDs composition and
somatic activity of 15-RVD GoldyTALENs. Scatter plot of
GoldyTALENs activities against their percentages of weak RVD
modules with the linear regression line. R2 = determination
coefficient and R= correlation coefficient.
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Table S1 15-RVD GoldyTALENs used in this study.
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introduced by 15-RVD GoldyTALENs.
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Table S3 Sequences of germline transmitted small indels
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